BRPI0710944A2 - uso de bactéria selecionada de ácido lático para reduzir cólicas infantis - Google Patents

uso de bactéria selecionada de ácido lático para reduzir cólicas infantis

Info

Publication number: BRPI0710944A2
Authority: BR; Brazil
Prior art keywords: reduce; lactic acid; acid bacteria; selected lactic; infantile colic
Prior art date: 2006-06-05

Application number

BRPI0710944A

Other languages

English (en)

Inventor

Möllstam Bo

Connolly Eamonn

Original Assignee

Biogaia Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-05

Filing date

2007-05-30

Publication date

2017-04-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38790468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0710944(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-05-30 Application filed by Biogaia Ab filed Critical Biogaia Ab

2017-04-18 Publication of BRPI0710944A2 publication Critical patent/BRPI0710944A2/pt

2020-12-29 Publication of BRPI0710944B1 publication Critical patent/BRPI0710944B1/pt

2021-05-25 Publication of BRPI0710944B8 publication Critical patent/BRPI0710944B8/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Mycology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

BRPI0710944A 2006-06-05 2007-05-30 cultura biologicamente pura, e, composição e método para reduzir cólica infantil BRPI0710944B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11/446,628 US7374924B2 (en)	2006-06-05	2006-06-05	Use of selected lactic acid bacteria for reducing infantile colic
US11/446,628		2006-06-05
PCT/SE2007/050371 WO2007142596A1 (en)	2006-06-05	2007-05-30	Use of selected lactic acid bacteria for reducing infantile colic

Publications (3)

Publication Number	Publication Date
BRPI0710944A2 true BRPI0710944A2 (pt)	2017-04-18
BRPI0710944B1 BRPI0710944B1 (pt)	2020-12-29
BRPI0710944B8 BRPI0710944B8 (pt)	2021-05-25

Family

ID=38790468

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0710944A BRPI0710944B8 (pt)	2006-06-05	2007-05-30	cultura biologicamente pura, e, composição e método para reduzir cólica infantil

Country Status (20)

Country	Link
US (3)	US7374924B2 (pt)
EP (1)	EP2040722B1 (pt)
JP (3)	JP4520531B2 (pt)
KR (2)	KR101308865B1 (pt)
CN (2)	CN102488717B (pt)
AU (2)	AU2007200434B2 (pt)
BR (1)	BRPI0710944B8 (pt)
CA (1)	CA2650546C (pt)
DK (1)	DK2040722T3 (pt)
GE (1)	GEP20125480B (pt)
HU (1)	HUE026416T2 (pt)
IL (1)	IL194779A0 (pt)
MX (1)	MX2008014869A (pt)
MY (1)	MY162708A (pt)
NZ (2)	NZ596788A (pt)
RU (1)	RU2435844C2 (pt)
SI (1)	SI2040722T1 (pt)
UA (1)	UA93911C2 (pt)
WO (1)	WO2007142596A1 (pt)
ZA (1)	ZA200809531B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7374924B2 (en) *	2006-06-05	2008-05-20	Biogaia Ab	Use of selected lactic acid bacteria for reducing infantile colic
RU2495927C2 (ru) *	2008-03-14	2013-10-20	Нестек С.А.	Синбиотическая смесь
AU2014221272B2 (en) *	2008-11-03	2016-01-21	Société des Produits Nestlé S.A.	A nutritional composition comprising probiotics and improving sleep patterns
US9034314B2 (en) *	2008-11-03	2015-05-19	Nestec S.A.	Nutritional composition comprising probiotics and improving sleep patterns
US20110104327A1 (en) *	2009-04-23	2011-05-05	Bacterfield International S.A.	Probiotic pet food
US20120121562A1 (en)	2009-07-31	2012-05-17	Nestec S.A.	Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
NL2004101C2 (en) *	2010-01-15	2011-07-18	Friesland Brands Bv	Ruminant il-10 and use in modulating immune response.
IT1401460B1 (it) *	2010-06-11	2013-07-26	Probiotical Spa	"ceppi di batteri probiotici produttori di vitamina b12"
KR101706100B1 (ko) *	2011-12-15	2017-02-15	삼성전자주식회사	성형한계선도 획득용 시험장치
EP2609813A1 (en) *	2011-12-30	2013-07-03	Nestec S.A.	Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system
UA118339C2 (uk) *	2012-09-03	2019-01-10	Біогайа Аб	Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
US11179427B2 (en)	2013-01-21	2021-11-23	Eth Zurich	Baby food composition comprising viable propionic acid-producing bacteria
CN111676171B (zh) *	2013-08-09	2023-06-06	Ab-生物股份有限公司	用于婴儿过度啼哭的益生菌
KR102154382B1 (ko) *	2014-01-23	2020-09-10	바이오가이아 에이비	위장 통증을 조절하는 제제의 선택
PL3212208T3 (pl) *	2014-10-29	2021-09-06	Biogaia Ab	Zastosowanie bakterii l. reuteri do zapobiegania lub leczenia dysbiozy mikrobioty we wczesnych fazach życia
EP3294308A4 (en)	2015-05-14	2019-03-06	University of Puerto Rico	PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
JP6529835B2 (ja) *	2015-06-23	2019-06-12	株式会社フィス	樹状細胞活性化剤
CN105219683B (zh) *	2015-11-04	2018-03-13	广东省农业科学院动物科学研究所	一株具有益生特征的罗伊氏乳杆菌菌株及其应用
WO2017117142A1 (en)	2015-12-28	2017-07-06	New York University	Device and method of restoring microbiota of newborns
CN106497840B (zh) *	2016-11-07	2019-06-21	江南大学	一种定向分离免疫调节性肠道乳杆菌的方法
WO2020020982A1 (en) *	2018-07-24	2020-01-30	Biogaia Ab	Selection and use of melatonin supporting bacteria to reduce infantile colic
CA3103356A1 (en) *	2018-07-24	2020-01-30	Biogaia Ab	Therapeutic methods using bacterial strains which are capable of increasing adenosine levels
IL287226B1 (en)	2019-04-17	2025-05-01	Biogaia Ab	Therapeutic microbubbles of probiotic bacteria
CN117925484B (zh) *	2024-03-19	2024-07-09	山东中科嘉亿生物工程有限公司	一株改善睡眠呼吸暂停的罗伊氏粘液乳杆菌jylb-101及其产品和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4518696A (en)	1983-01-11	1985-05-21	Chr. Hansen's Laboratory, Inc.	Stabilized liquid bacterial suspension for oral administration to animals
US5413960A (en)	1987-05-01	1995-05-09	Biogaia Ab	Antibiotic reuterin
US5458875A (en)	1990-06-15	1995-10-17	Biogaia Ab	In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5534253A (en)	1995-06-07	1996-07-09	Biogaia Ab	Method of treating enteropathogenic bacterial infections in poultry
EP0814822B1 (en)	1995-12-21	2003-05-07	BioGaia AB	Use of lactobacillus reuteri to inhibit cryptosporidiosis in mammals
US5837238A (en)	1996-06-05	1998-11-17	Biogaia Biologics Ab	Treatment of diarrhea
US5800813A (en)	1996-11-12	1998-09-01	Biogaia Biologics Ab	Treatment of cryptosporidium infections
KR19990024297A (ko)	1997-08-07	1999-04-06	오종석	인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en)	1998-03-16	2000-08-08	Biogaia Biologies Ab	Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
EP1034788A1 (en)	1999-03-11	2000-09-13	Société des Produits Nestlé S.A.	Lactic acid bacteria strains capable of preventing diarrhea
EP1344458A1 (en) *	2002-03-12	2003-09-17	Société des Produits Nestlé S.A.	Probiotic delivery system
EP1384483A1 (en)	2002-07-23	2004-01-28	Nestec S.A.	Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US7105336B2 (en)	2002-10-07	2006-09-12	Biogaia Ab	Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
AU2002347697B2 (en) *	2002-10-18	2008-03-20	Biogaia Ab	Method of improving immune function in mammals using lactobacillus reuteri strains
US20040208863A1 (en)	2003-01-30	2004-10-21	James Versalovic	Anti-inflammatory activity from lactic acid bacteria
US20040185032A1 (en) *	2003-03-18	2004-09-23	David Burrell	Compositions and methods for treating colic
PL1638414T3 (pl) *	2003-06-23	2009-12-31	Nestec Sa	Mleko modyfikowane niemowlęce lub następne
US7955834B2 (en) *	2004-06-03	2011-06-07	Biogaia Ab	Method for improved breast milk feeding to reduce the risk of allergy
US20060251634A1 (en) *	2005-05-06	2006-11-09	Ho-Jin Kang	Method of improving immune function in mammals using lactobacillus strains with certain lipids
US8603460B2 (en) *	2006-06-05	2013-12-10	Brogaia AB	Method of making a Lactobacillus reuteri with increased acid tolerance
US7374924B2 (en) *	2006-06-05	2008-05-20	Biogaia Ab	Use of selected lactic acid bacteria for reducing infantile colic

2006
- 2006-06-05 US US11/446,628 patent/US7374924B2/en active Active
2007
- 2007-02-01 AU AU2007200434A patent/AU2007200434B2/en active Active
- 2007-05-30 MX MX2008014869A patent/MX2008014869A/es active IP Right Grant
- 2007-05-30 SI SI200731741T patent/SI2040722T1/sl unknown
- 2007-05-30 MY MYPI20071631A patent/MY162708A/en unknown
- 2007-05-30 CN CN201110432103.1A patent/CN102488717B/zh active Active
- 2007-05-30 CA CA2650546A patent/CA2650546C/en active Active
- 2007-05-30 JP JP2009514239A patent/JP4520531B2/ja active Active
- 2007-05-30 KR KR1020107012584A patent/KR101308865B1/ko active Active
- 2007-05-30 BR BRPI0710944A patent/BRPI0710944B8/pt active IP Right Grant
- 2007-05-30 WO PCT/SE2007/050371 patent/WO2007142596A1/en active Application Filing
- 2007-05-30 NZ NZ596788A patent/NZ596788A/xx not_active IP Right Cessation
- 2007-05-30 CN CN2007800012187A patent/CN101374533B/zh active Active
- 2007-05-30 HU HUE07748532A patent/HUE026416T2/en unknown
- 2007-05-30 UA UAA200813986A patent/UA93911C2/ru unknown
- 2007-05-30 RU RU2008147883/10A patent/RU2435844C2/ru active
- 2007-05-30 EP EP07748532.4A patent/EP2040722B1/en active Active
- 2007-05-30 KR KR1020087026182A patent/KR101030661B1/ko active Active
- 2007-05-30 DK DK07748532.4T patent/DK2040722T3/en active
- 2007-05-30 NZ NZ572359A patent/NZ572359A/en unknown
- 2007-05-30 GE GEAP200711000A patent/GEP20125480B/en unknown
- 2007-05-30 ZA ZA200809531A patent/ZA200809531B/xx unknown
- 2007-10-29 US US11/978,417 patent/US9057112B2/en active Active
2008
- 2008-10-22 IL IL194779A patent/IL194779A0/en active IP Right Grant
2010
- 2010-04-14 JP JP2010092728A patent/JP2010202654A/ja active Pending
- 2010-07-14 AU AU2010202976A patent/AU2010202976B2/en active Active
2012
- 2012-01-23 US US13/355,585 patent/US9340840B2/en active Active
2013
- 2013-03-27 JP JP2013065540A patent/JP5865283B2/ja active Active

Also Published As

Publication number	Publication date
EP2040722A1 (en)	2009-04-01
EP2040722A4 (en)	2010-06-02
JP4520531B2 (ja)	2010-08-04
JP2013173749A (ja)	2013-09-05
SI2040722T1 (sl)	2016-02-29
US20120121564A1 (en)	2012-05-17
NZ596788A (en)	2013-03-28
AU2010202976A1 (en)	2010-08-05
US20080131414A1 (en)	2008-06-05
BRPI0710944B1 (pt)	2020-12-29
JP2009539371A (ja)	2009-11-19
RU2008147883A (ru)	2010-07-20
CN101374533A (zh)	2009-02-25
JP5865283B2 (ja)	2016-02-17
EP2040722B1 (en)	2015-11-11
MY162708A (en)	2017-07-14
GEP20125480B (en)	2012-04-25
HK1125840A1 (en)	2009-08-21
JP2010202654A (ja)	2010-09-16
CN102488717A (zh)	2012-06-13
CN102488717B (zh)	2018-03-27
US9340840B2 (en)	2016-05-17
KR20090015903A (ko)	2009-02-12
US7374924B2 (en)	2008-05-20
BRPI0710944B8 (pt)	2021-05-25
IL194779A0 (en)	2009-08-03
CN101374533B (zh)	2012-02-01
HUE026416T2 (en)	2016-07-28
KR101308865B1 (ko)	2013-09-17
UA93911C2 (ru)	2011-03-25
AU2010202976B2 (en)	2012-12-20
NZ572359A (en)	2011-12-22
MX2008014869A (es)	2008-12-05
WO2007142596A1 (en)	2007-12-13
KR20100080565A (ko)	2010-07-08
AU2007200434B2 (en)	2010-09-02
US9057112B2 (en)	2015-06-16
RU2435844C2 (ru)	2011-12-10
CA2650546C (en)	2011-08-02
KR101030661B1 (ko)	2011-04-20
ZA200809531B (en)	2010-03-31
AU2007200434A1 (en)	2007-12-20
CA2650546A1 (en)	2007-12-13
US20070280913A1 (en)	2007-12-06
DK2040722T3 (en)	2016-02-01

Publication	Publication Date	Title
BRPI0710944A2 (pt)	2017-04-18	uso de bactéria selecionada de ácido lático para reduzir cólicas infantis
BRPI0810881A2 (pt)	2014-10-21	Uso de bactérias do ácido lático selecionadas para redução da aterosclerose
BRPI1009920A2 (pt)	2016-03-15	composições bacterianas para profilaxina e tratamento de doença degenerativa.
HRP20170926T1 (hr)	2017-09-22	Antisens kompozicije i postupci za pripremu i uporabu istih
BRPI0819821A2 (pt)	2015-05-26	Preparação e uso de polianilinas para tratamento de água
BR112012001812A2 (pt)	2016-03-15	uso de bactérias de ácido lático ou bifidobacterium ou uma mistura dessas
EP2406250A4 (en)	2012-11-21	HAMMER OF ACT ACTIVITY
ZA201005798B (en)	2013-01-30	Treatment of microbial infections
PT2504298T (pt)	2016-12-29	Preparação e purificação de iodoxanol
EP1988155A4 (en)	2009-05-06	LACTIC ACID BACTERIUM CAPABLE OF PRODUCING AMINO-ACUTE ACID
IL235943A0 (en)	2015-01-29	Genistein salts, their crystalline forms, preparations containing them and their uses
BRPI0912687A2 (pt)	2016-01-26	uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
AP3521A (en)	2016-01-11	Crystalline forms of hydrochloride salt of (4a-r,9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2,3,4,4a,9,9a-hexahydro-1h-indeno [2,1-b]pyridine-6-carbonitrile and their use as hsd 1 inhibitors
EP2405756A4 (en)	2012-06-13	HAMMER OF ACT ACTIVITY
BR112012007642A2 (pt)	2016-08-09	"composições líquidas precursoras para tratamento de difusões orais com ph-dependente de liberação sustentada e respectivo uso"
DOP2010000373A (es)	2011-01-15	Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas
BRPI0816290A2 (pt)	2014-10-14	Isolamento de micro-organismos formadores de péletes
DE602007014179D1 (de)	2011-06-09	Herstellung von polytrimethylen-etherglykol
FR2941939B1 (fr)	2011-12-09	Preparation de chlorure de calcium epure
IL248077B (en)	2020-05-31	Formulations, salts and polymers of transnorsertraline and their uses
IL213177A0 (en)	2011-07-31	Crystal forms, methods of preparation, pharmaceutical compositions and uses of nicousamide
FI20096402A0 (fi)	2009-12-28	Veriryhmästatuksen käyttö II
GB0809761D0 (en)	2008-07-09	Diagnosis of mycobacterial infections
EP2290063A4 (en)	2011-07-27	SIRNA FOR HUMAN OSTEOPONTIN
FI20095792L (fi)	2011-01-16	Ihmissolujen käyttö

Legal Events

Date	Code	Title	Description
2012-02-28	B15V	Prolongation of time limit allowed	Free format text: REQUERENTE DA DEVOLUCAO DE PRAZO: A DEPOSITANTE - BIOGAIA AB. DESPACHO: CONCEDIDA A DEVOLUCAO DE PRAZO PARA ENTRADA NA FASE NACIONAL DO PEDIDO PCT/SE2007/050371, DE 30/05/2007.
2012-03-06	B11Z	Dismissal: petition dismissal - article 216, par 2 of industrial property law	Free format text: INTERESSADA: A DEPOSITANTE - BIOGAIA AB. DESPACHO: ARQUIVADA A PETICAO NO 200801252659 (RJ), DE 11/12/2008 POR AUSENCIA DO INSTRUMENTO DE PROCURACAO CONFORME ART. 216 2O DA LPI.
2014-12-16	B12F	Other appeals [chapter 12.6 patent gazette]
2019-06-25	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2020-01-28	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-02-18	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-07-07	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-10-13	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-12-29	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/12/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/05/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2022-03-03	B22B	Petition not considered [chapter 22.2 patent gazette]	Free format text: PI0710944-0: NAO CONHECIDA A PETICAO NO 870210061832, DE 07/07/2021, EM VIRTUDE DO DISPOSTO NO ART. 219 , INCISO II DA LPI
2022-05-17	B12F	Other appeals [chapter 12.6 patent gazette]	Free format text: RECURSO: 870220037926 - 2/05/2022